Clinical effects on CA 15-3 level of cyclosporin A as a chemosensitiser in chemoresistant metastatic breast cancer.
C
C
Maulard
J P
JP
Marie
S
S
Delanian
M
M
Housset
D000230:Adenocarcinoma / Q000188:drug therapy; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy*; D016572:Cyclosporine / Q000008:administration & dosage*; D004351:Drug Resistance; D015251:Epirubicin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008875:Middle Aged
D015295:Antigens, Tumor-Associated, Carbohydrate; D015251:Epirubicin; D016572:Cyclosporine